11/18 - Erenumab- (May 2018)
Drug Name:
11/18 - Erenumab- (May 2018)
List Of Brands:
Indication Type Description:
Indication:
U.S. FDA APPROVED DRUGS DURING 2018
Sr.No- 11
Name of the Drug- AIMOVIG
Active Ingredient - Erenumab- aooe
Pharmacological Classification-
For the preventive treatment of migraine
Date of Approval- 5-17-2018
(Ref- FDA approved List 2018)